Envoy Medical (COCH) Other financing activities (2021 - 2026)

Envoy Medical has disclosed Other financing activities across 4 years of filings, most recently posting $208000.0 for Q1 2026.

• Other financing activities for Q1 2026 came in at $208000.0, down 10.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $37000.0 (down 95.85% YoY), and the FY2025 annual result was $62000.0, down 93.23% from the prior year.
• Other financing activities came in at $208000.0 for Q1 2026 at Envoy Medical, up from -$574000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $262000.0 in Q2 2024 to a low of -$574000.0 in Q4 2025.
• The 3-year median for Other financing activities is $213000.0 (2024), against an average of $131777.8.
• Peak annual rise in Other financing activities reached 9.24% in 2025, while the deepest fall reached 369.48% in 2025.
• Envoy Medical's Other financing activities stood at $213000.0 in 2024, then tumbled by 369.48% to -$574000.0 in 2025, then jumped by 136.24% to $208000.0 in 2026.
• The last three Other financing activities figures came in at $208000.0 (Q1 2026), -$574000.0 (Q4 2025), and $167000.0 (Q3 2025), per Business Quant data.